Literature DB >> 496496

The treatment of postperfusion bleeding using epsilon-aminocaproic acid, cryoprecipitate, fresh-frozen plasma, and protamine sulfate.

C J Lambert, A J Marengo-Rowe, J E Leveson, R H Green, J P Thiele, G F Geisler, M Adam, B F Mitchel.   

Abstract

The evaluation of excessive hemorrhage was carried out in 774 patients after cardiopulmonary bypass. Excessive hemorrhage was defined in any adult patient as chest tube drainage of more than 600 ml within the first eight hours after operation. Using the prothrombin time, partial thromboplastin time, fibrinogen level, and tri-F titer tests, it was possible to differentiate medical from surgical bleeding. Hyperfibrinolytic bleeding was the most frequently identifiable coagulation disorder and occurred in 159 patients (20%). All these patients were successfully treated with Amicar (epsilon-aminocaproic acid) alone, or with Amicar supplemented with cryoprecipitate or fresh-frozen plasma. Three patients (0.4%) were noted to have residual heparin and required additional protamine sulfate. Five patients (0.6%) had normal coagulation studies and required immediate reexploration. The overall blood consumption per patient was 2.1 units of packed cells. Whole blood and platelets were not used.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 496496     DOI: 10.1016/s0003-4975(10)63153-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  N-acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid.

Authors:  W A De Backer; B Amsel; P G Jorens; L Bossaert; P S Hiemstra; P van Noort; F J van Overveld
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

Review 2.  Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency.

Authors:  J F Hardy; S Bélisle
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

Review 3.  Antifibrinolytic therapy in cardiac surgery.

Authors:  R H Chen; O H Frazier; D A Cooley
Journal:  Tex Heart Inst J       Date:  1995

Review 4.  Perioperative management of drug therapy, clinical considerations.

Authors:  M S Smith; H Muir; R Hall
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

5.  Activation status of platelet aggregates and platelet microparticles shed in sheared whole blood.

Authors:  N P Rhodes; A P Shortland; A Rattray; R A Black; D F Williams
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

Review 6.  Natural and synthetic antifibrinolytics in cardiac surgery.

Authors:  J F Hardy; J Desroches
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

7.  Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.

Authors:  A Penta de Peppo; M D Pierri; A Scafuri; R De Paulis; G Colantuono; E Caprara; F Tomai; L Chiariello
Journal:  Tex Heart Inst J       Date:  1995

Review 8.  Hematologic and oncologic complications in the critically ill child.

Authors:  S McIntosh
Journal:  Yale J Biol Med       Date:  1984 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.